The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly diseases. As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of science by modernizing clinical trials that support more efficient, less costly drug development. Adaptive platform trials deliver an unmatched accelerated time from discovery in the lab to implementation in the clinic resulting in better treatments and lives saved. 



Clinical Trials

Life Sciences

Health Care

Biotechnology

Global Coalition for Adaptive Research

Meredith Buxton

Ashley A. Powell

Rachel Rosenstein-Sisson

Matthew Viva

Tracey Roberts

Adam Johnson

Rob Murray

Rachael Coleman

The Leadership Team at GCAR spearheads the strategic direction and operational oversight of the organization. Comprising the Chief Business Officer, CEO & President, CFO and COO, and Vice President of Trial Operations, this team ensures the alignment of resources, strengthens partnerships, manages financial health, and streamlines trial operations to accelerate the discovery and development of treatments for rare and deadly diseases.

Leadership Team

Clinical Operations and Trial Management

Leadership Team

About

Team members

Other teams at Global Coalition for Adaptive Research

Clinical Operations and Trial Management